Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
https://news.sky.com/story/amp/covid-19-ireland-brings-in-new-restrictions-ahead-of-christmas-due-to-very-stark-health-advice-12485681
Surely MHC must be a major beneficiary as a result of all these new restrictions etc. Everything points to more testing one must assume.
roly12 - to have come through a year moulding the business to grab the Covid opportunity - from a disaster women's fertility product (which on the face of it should have scored big time), shows excellent business acumen from a small team. The thousands and thousands of pcr tests they've processed and end the year with such a realistically brilliant TrustPilot score, shows excellent efficiency too.
We've been told along the way, how cash flow positive they are and now profit generative - although we can only guess at numbers right now. I'm hoping we will have an early indication just how profitable early in the new Year.
I don't think we've been given any pricing indications of the dna test kits but their link to Boots and Lloyds Pharmacy means presumably they'll want to service the products primarily via them. There's a US company, multi million sales which I wonder if MHC has based it's own business model on - letsgetchecked.com. They appear a very successful company offering a very wide range of tests - eg coeliac test at £59 and fertility tests from £69 - £119. To me, MHC has every possibility of doing well with the Boots/ Lloyds connection in competition with letsgetchecked.com. It clearly is a massive market and MHC has shown it can handle the business pressure.
So, in summary, the outlook looks good for us in the near and long term. The shares offer the potential of a multi-bagger from these levels and I don't think the market has yet understood the Company's potential. We'll be in a better position to understand, once the end year results are announced.
Hello dactions, I saw some selling pressure tuesday, mainly because some thought there might be an announcement about PCR testing on the monday, not on wednesday though, I use ADVFN live as it is accurate. My SP forecast of two years is based on new product range launched during 2022, this range very different to PCR product so therefore it might take up to a year to see how the consumer reacts to the range and only then will we get an idea of numbers, I would be hopeful that the range will be in boots/lloyds which on its own is huge, but MHC will need to put aside quite a sum for marketing / brand awareness, if all this pans out and the numbers are enough then I would expect a SP in the range that I quoted within that timeframe. I look at MKT CAP as well as SP and ask myself the question, will the company be worth that ? based on my SP forecast.. so let us say a SP of 15p within two years, this equates to a MKT CAP of £120 M, you get my point, Roly.
https://news.sky.com/story/covid-19-omicron-has-substantial-ability-to-evade-immunity-from-previous-coronavirus-infection-12484840
Time to get serious on testing,testing and more testing. Let’s have a update from the board soon pls. Time to put shareholders first and let us all be reassured. Time for a blue Friday. GLA
Roly12 - you say yesterday's fall strange, on no news or selling pressure but the latter happened in a very big way yesterday. You only have to look at all the delayed deals which were in themselves individually sizable and shown as non-classified - but they were undoubtedly Sells. The share had been ramped hard by some on here - goodness knows what it was like on ADVFN.
However, I fully agree with your insight that MHC are trying to establish there own brand and I couldn't agree with you more that , if successful the SP will be in the high teens. You say 2 years and I guess that is realistic but it could as easily happen a lot sooner dependent whether we're all still doing Covid-19 or whether MHC is focusing instead on the new products.
Jamrock, I am not panicking, just was trying to highlight that i found the fall strange, on no news or selling pressure, I sold ODX @ 51p to buy here @ .17p so for once got that right up till now, still need 4p to break even (incl ODX loss), but think it will come. The fact that they are in Boots & lloyds I would hope/expect that both will stock the new range of at home testing products, it is the way testing is going instead of clogging up GP's waiting rooms. As I said here before MHC are trying to establish their own brand, a very tough business but if successful the SP here will be high teens within two years, am happy to hold and see what happens. Roly
Roly12
My advice is don’t panic. I’m also down heavily and I have been buying at many stages. I originally brought a lot higher months ago and lower a few weeks ago and been buying over the last few days. I made my position clear and I’ll stick with my strategy. I believe in the company and I’m investing based a the figures and facts. Nothing has changed my view and being a long term investor I expect ups and downs but I will say once again I won’t panic. I know it’s been a painful few days for all of us but selling into a panic can be costly when it’s turns again. I still don’t see what caused such a huge sell off and can only assume automatic stop losses were triggered. I think the fundamentals haven’t changed in my mind and Covid isn’t going away. I’ve been in this stock a long time and happy to ride this out and follow my strategy. Everyone has different opinions but always know your own personal risks. I’m sure those of us who have been in for a long time believe in the board and strategy. Now they need to deliver the results. Honestly try not to panic even though it’s been a horrible few days and remember we’ve been to 7p and back down to 1.5p and now back at 2.5p?. I believe the buyers will be back and the path will continue whilst the board keep delivering and updating the market. GLA
I wonder how much of todays fall was due to the Abingdon Health placing factor......it must surely have contributed to it......
Jamrock, 25% down in two days !! I watched the close live on ADVFN, it should of closed at 2.65 which was the price at 1635, then 1 trade flashed up @ 2.45 followed by the last trade @2.50 which was the recorded close, this is being pulled down and not by selling, I wonder why ? Roly.
Today was a day that caught most of us off guard. I personally took the opportunity to top up. I hope I made the right call. I personally expected a pull back to 2.9p. Thought it was overdone but as I always say nothing goes up in a straight line. Nothing has changed and my view remains the same. I expect this to head higher and I’m personally positioning my self with that view in mind. Let’s hope tomorrow is better and stay positive. Don’t be disheartened by today if your in it for the long run. GLA
Excellent bit of targeting on students. A huge market.
Shows they are thinking wider on sales and outside the box.
FortKnight - thanks for the link.
That must be a first for MHC - very enterprising - and hopefully they'll offer it more widely through the educational sector.
Good find, Thanks. Given that the SP was raising here before the news about the new strain of covid, I to am surprised by the 20% drop the past two days, but will hold as I want to see how the market reacts to the new product line up 2022. PCR testing will last until COVID has mutated so much that it is no longer a risk to society, how long that will be no one knows atm. Roly
another profitable avenue being pursued
https://www.ucl.ac.uk/coronavirus/information-ucl-students/discounted-pcr-testing-students-arriving-overseas
Pre-departure Covid testing for travellers returning to the UK would be "valuable", the government's Sage advisory committee have said.
It also says the government's policy of asking travellers to take a test two days after they arrive would "identify significantly fewer cases" than extra tests on days five or eight.
The advice is in the minutes of a meeting held on Monday seen by the BBC.
Earlier this week Labour called for the reintroduction of pre-departure tests.
Omicron may need 'stringent response' - scientists
MPs back tighter mask and self-isolation rules
And the Scottish and Welsh governments have argued that travellers should be required to take additional coronavirus tests, eight days after their arrival.
The document, which has not yet been published, also says that the government should be preparing for "a potentially very significant wave with associated hospitalisations" now, even before scientists have established how dangerous the Omicron variant might be.
But the advisors stress how much uncertainty there is around the variant's transmissibility and the effectiveness of the vaccine and some of their warnings are based on a theoretical worst case.
The emergence of the new coronavirus variant prompted the government to introduce new travel restrictions, which came into force on Tuesday.
It means that everyone entering the UK (other than those coming from the Common Travel Area that covers the Channel Islands and Ireland) must take a PCR test by the end of the second day after their arrival and self-isolate until they receive a negative result.
On Tuesday, Labour called on the government to go further and reintroduce pre-departure Covid tests for anyone travelling to the UK.
Labour's new shadow home secretary Yvette Cooper said introducing additional test was "an urgent requirement"
In a letter to the home secretary and health secretary, Labour's shadow home office and health ministers Yvette Cooper and Wes Streeting wrote: "Currently it is possible for people to travel to the UK on crowded planes, stand in crowded departure halls, get on crowded tubes, buses and trains home to rejoin family or housemates without taking a test at any point along the way - not even a lateral flow test at the airport before they get on a plane.
"Given that Omicron has now been identified in 19 different countries, this basic testing is an urgent requirement."
Scottish First Minister Nicola Sturgeon and Welsh First Minister Mark Drakeford have also argued for tougher travel restrictions for people arriving in the UK.
On Tuesday, they wrote to Prime Minister Boris Johnson proposing that people should self-isolate for eight days, with tests on both day two and day eight.
Earlier this week, Downing Street defended the government's approach which it said was "the proportionate one to the evidence we currently have available".
"Introducing further isolation and testing requirements would have a detrimental ef